GlassScriptPhysician profile
Krista Dennis
NPI 1932674223
$2,536.38
in general payments reported to CMS, 2019-2025
38 companies · $593 in 2025
The $593 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,250 · 2022: $132 · 2023: $208 · 2024: $354 · 2025: $593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,155.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $260.09 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $252.53 | 2021-2023 | |
| Veloxis Pharmaceuticals, INC. | $210.54 | 2022-2025 | Envarsus |
| Novo Nordisk INC | $186.07 | 2021-2025 | Ozempic |
| Travere Therapeutics, INC. | $141.38 | 2024-2025 | |
| Otsuka America Pharmaceutical, INC. | $128.04 | 2025 | Jynarque |
| Merck Sharp & Dohme LLC | $127.61 | 2023-2025 | Prevymis, Dificid |
| Mallinckrodt Hospital Products INC. | $113.98 | 2024-2025 | Acthar |
| Biohaven Pharmaceuticals, INC. | $100.17 | 2021 | |
| Sanofi-Aventis U.S. LLC | $97.11 | 2021 | |
| Abbvie INC. | $95.69 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $90.87 | 2021-2025 | Livtencity |
| Dexcom, INC. | $71.74 | 2021 | |
| Nevro Corp. | $56.97 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $56.66 | 2021-2024 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $47.82 | 2021 | |
| Tandem Diabetes Care, INC. | $45.33 | 2021 | |
| Antares Pharma, INC. | $40.12 | 2021 | |
| Mannkind Corporation | $33.99 | 2021 | |
| Amgen INC. | $28.20 | 2025 | Krystexxa |
| Novartis Pharmaceuticals Corporation | $28.10 | 2024 | |
| Calliditas Therapeutics US INC. | $24.57 | 2024 | |
| Amneal Pharmaceuticals LLC | $24.31 | 2021 | |
| One Lambda, INC. | $24.21 | 2025 | |
| Kci USA, INC. | $23.66 | 2023 | Prevena, V.A.C. Veraflo Cleanse Choice, Activ.A.C. |
| Kyowa Kirin, INC. | $22.08 | 2024 | Crysvita |
| Renalytix Ai, INC. | $20.12 | 2022 | |
| Ibsa Pharma INC. | $19.69 | 2021 | |
| Ardelyx, INC. | $19.48 | 2025 | Ibsrela |
| Vifor Pharma, INC. | $18.95 | 2023 | Veltassa |
| Amarin Pharma, INC. | $18.10 | 2021 | |
| Alnylam Pharmaceuticals INC. | $17.27 | 2025 | Givlaari |
| Lifescan, INC. | $16.67 | 2021 | |
| Fresenius USA Marketing, INC. | $16.58 | 2022 | |
| Medtronic, INC. | $15.92 | 2021 | |
| Clarus Therapeutics INC. | $15.90 | 2021 | |
| Zealand Pharma US, INC. | $13.78 | 2021 | |
| Becton, Dickinson and Company | $12.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krista Dennis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.